60 likes | 165 Views
Agenda. 3:00 PM Introduction to Workshop Barry Reisberg, M.D. 3:05 PM Cognitive dynamics: how variability in brain Kenneth Rockwood M.D., FRCPC, FRCP function influences the risk of cognitive decline
E N D
Agenda 3:00 PM Introduction to Workshop Barry Reisberg, M.D. 3:05 PM Cognitive dynamics: how variability in brain Kenneth Rockwood M.D., FRCPC, FRCP function influences the risk of cognitive decline 3:35 PM Current Knowledge of Methodologies for Barry Reisberg, M.D. Clinical Trials in Pre-MCI Persons with Subjective Cognitive Impairment (SCI) 4:25 PM Discussion of Current Knowledge and Joel Sadavoy M.D., FRCPC Methodologies 4:35 PM Discussion of Clinical Instrumentation for Barry Reisberg, M.D. Subject Selection and Assessment 4:55 PM Subject Interview Workshop Faculty and Participants 5:25 PM Final Discussion Joel Sadavoy M.D., FRCPC
Workshop on Methodologies for Clinical Trials in Pre-MCI Persons with Subjective Cognitive Impairment (SCI) B. Reisberg, M.D. New York University School of Medicine New York, N.Y., USA Kenneth Rockwood M.D. Dalhousie University Halifax, Nova Scotia, Canada Joel Sadavoy M.D. University of Toronto Toronto, Ontario, Canada
Barry Reisberg, M. D. Professor of Psychiatry Director, Fisher Alzheimer's Disease Program Clinical Director, Aging & Dementia Research Center Director, Clinical Core, NYU Alzheimer's Disease Center New York University School of Medicine
Workshop Moderator Joel Sadavoy M.D., FRCPC Professor of Psychiatry, University of Toronto,Sam and Judy Pencer Chair in Applied General Psychiatry,Director Cyril & Dorothy, Joel & Jill Reitman Institute for Alzheimer's Support and Training,Head Geriatric and Community Psychiatry Programs Mount Sinai Hospital
Workshop Presenter Kenneth Rockwood M.D., FRCPC, FRCP Professor of Medicine (Geriatric Medicine & Neurology) andKathryn Allen Weldon Professor of Alzheimer ResearchDalhousie UniversityHalifax NS CanadaB3H 2E1
Agenda 3:00 PM Introduction to Workshop Barry Reisberg, M.D. 3:05 PM Cognitive dynamics: how variability in brain Kenneth Rockwood M.D., FRCPC, FRCP function influences the risk of cognitive decline 3:35 PM Current Knowledge of Methodologies for Barry Reisberg, M.D. Clinical Trials in Pre-MCI Persons with Subjective Cognitive Impairment (SCI) 4:25 PM Discussion of Current Knowledge and Joel Sadavoy M.D., FRCPC Methodologies 4:35 PM Discussion of Clinical Instrumentation for Barry Reisberg, M.D. Subject Selection and Assessment 4:55 PM Subject Interview Workshop Faculty and Participants 5:25 PM Final Discussion Joel Sadavoy M.D., FRCPC